• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pediatr Pulmonol . Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of

tetano

Editor, Senior Moderator
Pediatr Pulmonol


. 2023 Jul 26.
doi: 10.1002/ppul.26613. Online ahead of print. Characteristics and management of patients with SARS-CoV2 infection admitted to pediatric intensive care units: Data analysis of the Spanish national multicenter registry

María Slöcker Barrio[SUP] 1 2 3 [/SUP], Sylvia Belda Hofheinz[SUP] 3 4 [/SUP], Carmina Guitart Pardellans[SUP] 5 [/SUP], Alberto García-Salido[SUP] 6 [/SUP], Juan Carlos de Carlos Vicente[SUP] 7 [/SUP], Maite Cuervas-Mons Tejedor[SUP] 8 [/SUP], Alexandra Hernández Yuste[SUP] 9 [/SUP], Ainhoa Jiménez Olmos[SUP] 10 [/SUP], Elvira Morteruel Arizcuren[SUP] 11 [/SUP], Maria García-Besteiro[SUP] 12 [/SUP], Cristina Calvo Monge[SUP] 13 [/SUP], Miguel Rodríguez Rubio[SUP] 14 [/SUP], David Roca Pascual[SUP] 15 [/SUP], Lorena Bermúdez Barrezueta[SUP] 16 [/SUP], Carmen Martínez Padilla[SUP] 17 [/SUP], Beatriz Huidobro Labarga[SUP] 18 [/SUP], Ignacio Oulego-Erroz[SUP] 19 [/SUP], Sonia Sanchíz Cárdenas[SUP] 20 [/SUP], Corsino Rey Galan[SUP] 21 [/SUP], Maria Soledad Holanda Peña[SUP] 22 [/SUP], Pablo González Navarro[SUP] 23 [/SUP], Rafael González Cortés[SUP] 1 2 3 [/SUP]; Spanish Pediatric Intensive Care Society working group on SARS-Cov2 infection



Affiliations
Abstract

Introduction: The purpose of this study is to describe the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) disease characteristics and management in children admitted to the pediatric intensive care units (PICU).
Methods: The present study was based on a national multicentric prospective registry including PICU patients with SARS-CoV2 infection or symptoms of multisystem inflammatory syndrome in children (MIS-C).
Results: A total of 298 patients were admitted to 41 different Spanish PICUs. A total of 76% of them were previously healthy. The most frequent manifestation was MIS-C (69.8%). On admission, 59.4% of patients did not have respiratory distress, and only 17.4% needed conventional mechanical ventilation (MV). The need for MV was associated with age (incidence rate ratios [IRR] 1.21, p < .012), pediatric sequential organ failure assessment score (p-SOFA) Score (IRR 1.12, p = .001), and need for transfusion (IRR 4.5, p < .004) in MIS-C patients, and with vasoactive drug use (IRR 2.73, p = .022) and the diagnosis of acute respiratory distress syndrome (IRR 2.83, p = .018) in patients admitted for other reasons. During the first day of admission, 56% of patients met shock criteria and 50.7% needed vasoactive drugs. In MIS-C patients, their use was associated with higher p-SOFA score (IRR 1.06, p < .001) and with the diagnosis of shock (IRR 5.78, p < .001). In patients without MIS-C, it was associated with higher p-SOFA score (IRR 1.05, p = .022). The mortality rate was 3%, being lower in MIS-C patients compared to patients admitted for other reasons (0.5% vs. 9.4%, p < .001). It was also lower in previously healthy patients compared to patients with previous comorbidities (0.9% vs. 9.7%, p < .001).
Conclusions: Severe SARS-CoV2 infection is uncommon in the pediatric population. In our series, respiratory distress was rare, being MIS-C the most frequent cause of PICU admission related to SARS-CoV2. In most cases, the course of the disease was mild except in children with previous diseases.

Keywords: ARDS; MIS-C; SARS-COV2; mechanical ventilation; pediatric intensive care.

 
Back
Top Bottom